Abstract
Acetaminophen can adversely affect the liver especially when overdosed. We used whole blood as a surrogate to identify genes as potential early indicators of an acetaminophen-induced response. In a clinical study, healthy human subjects were dosed daily with 4 g of either acetaminophen or placebo pills for 7 days and evaluated over the course of 14 days. Alanine aminotransferase (ALT) levels for responders to acetaminophen increased between days 4 and 9 after dosing, and 12 genes were detected with expression profiles significantly altered within 24 h. The early responsive genes separated the subjects by class and dose period. In addition, the genes clustered patients who overdosed on acetaminophen apart from controls and also predicted the exposure classifications with 100% accuracy. The responsive genes serve as early indicators of an acetaminophen exposure, and their gene expression profiles can potentially be evaluated as molecular indicators for further consideration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ferner RE, Dear JW, Bateman DN . Management of paracetamol poisoning. BMJ 2011; 342: d2218.
Manthripragada AD, Zhou EH, Budnitz DS, Lovegrove MC, Willy ME . Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United States. Pharmacoepidemiol Drug Saf 2011; 20: 819–826.
Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364–1372.
Nourjah P, Ahmad SR, Karwoski C, Willy M . Estimates of acetaminophen (paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf 2006; 15: 398–405.
Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947–954.
Bronstein AC, Spyker DA, Cantilena LR Jr., Green JL, Rumack BH, Giffin SL 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila) 2009 47: 911–1084.
Mitka M . FDA asks physicians to stop prescribing high-dose acetaminophen products. JAMA 2014; 311: 563.
Kuehn BM . FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen. JAMA 2009; 302: 369–371.
Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006; 296: 87–93.
Heard KJ . Acetylcysteine for acetaminophen poisoning. N Engl J Med 2008; 359: 285–292.
Chou JW, Paules RS, Bushel PR . Systematic variation normalization in microarray data to get gene expression comparison unbiased. J Bioinform Comput Biol 2005; 3: 225–241.
Johnson WE, Li C, Rabinovic A . Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8: 118–127.
Neter J, Kutner MH, Nachtsheim CJ, Wasserman W . Applied Linear Statistical Models. 4th edn. Irwin: Chicago, IL, USA, 1996 xv, 720 p.p.
Storey JD . A direct approach to false discovery rates. J R Stat Soc Series B Stat Methodol 2002; 64: 479–498.
Storey JD . The positive false discovery rate: a Bayesian interpretation and the q-value. Ann Stat 2003; 31: 2013–2035.
Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD et al. Functional discovery via a compendium of expression profiles. Cell 2000; 102: 109–126.
Hastie T, Hastie T, Tibshirani R, Friedman JH . The Elements of Statistical Learning: Data Mining, Inference, and Prediction. Springer: New York, USA, 2001 xvi, 533 p.pp.
Omer A, Singh P, Yadav NK, Singh RK . An overview of data mining algorithms in drug induced toxicity prediction. Mini Rev Med Chem 2014; 14: 345–354.
Beyer RP, Fry RC, Lasarev MR, McConnachie LA, Meira LB, Palmer VS et al. Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses. Toxicol Sci 2007; 99: 326–337.
Heinloth AN, Boorman GA, Foley JF, Flagler ND, Paules RS . Gene expression analysis offers unique advantages to histopathology in liver biopsy evaluations. Toxicol Pathol 2007; 35: 276–283.
Baken KA, Pennings JL, Jonker MJ, Schaap MM, de Vries A, van Steeg H et al. Overlapping gene expression profiles of model compounds provide opportunities for immunotoxicity screening. Toxicol Appl Pharmacol 2008; 226: 46–59.
Bushel PR . Clustering of mixed data types with application to toxicogenomics. PhD dissertation 2005.
Poulsen HE, Petersen P, Vilstrup H . Quantitative liver function and morphology after paracetamol administration to rats. Eur J Clin Invest 1981; 11: 161–164.
Lewis MJ, Pelham HR . Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulum. Cell 1992; 68: 353–364.
Handford M, Rodriguez-Furlan C, Orellana A . Nucleotide-sugar transporters: structure, function and roles in vivo. Braz J Med Biol Res 2006; 39: 1149–1158.
Parrado A, Robledo M, Moya-Quiles MR, Marin LA, Chomienne C, Padua RA et al. The promyelocytic leukemia zinc finger protein down-regulates apoptosis and expression of the proapoptotic BID protein in lymphocytes. Proc Natl Acad Sci USA 2004; 101: 1898–1903.
Toyonaga T, Hino O, Sugai S, Wakasugi S, Abe K, Shichiri M et al. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc Natl Acad Sci USA 1994; 91: 614–618.
Krenkel O, Mossanen JC, Tacke F . Immune mechanisms in acetaminophen-induced acute liver failure. Hepatobiliary Surg Nutr 2014; 3: 331–343.
Liu ZX, Kaplowitz N . Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 2006; 2: 493–503.
Masson MJ, Peterson RA, Chung CJ, Graf ML, Carpenter LD, Ambroso JL et al. Lymphocyte loss and immunosuppression following acetaminophen-induced hepatotoxicity in mice as a potential mechanism of tolerance. Chem Res Toxicol 2007; 20: 20–26.
Jaeschke H, Williams CD, Ramachandran A, Bajt ML . Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int 2012; 32: 8–20.
Radici L, Bianchi M, Crinelli R, Magnani M . Ubiquitin C gene: structure, function, and transcriptional regulation. Adv Biosci Biotechnol 2013; 4: 1057–1062.
Nagy G, Kardon T, Wunderlich L, Szarka A, Kiss A, Schaff Z et al. Acetaminophen induces ER dependent signaling in mouse liver. Arch Biochem Biophys 2007; 459: 273–279.
McQueen CA . Comprehensive Toxicology Elsevier Science & Technology Books: San Diego, Saint Louis, USA, 2010.
Yoshida H . ER stress and diseases. FEBS J 2007; 274: 630–658.
Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009; 106: 4402–4407.
Ward J, Kanchagar C, Veksler-Lublinsky I, Lee RC, McGill MR, Jaeschke H et al. Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis. Proc Natl Acad Sci USA 2014; 111: 12169–12174.
Kumar BS, Chung BC, Kwon OS, Jung BH . Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics. J Appl Toxicol 2012; 32: 505–520.
van Swelm RP, Laarakkers CM, van der Kuur EC, Morava-Kozicz E, Wevers RA, Augustijn KD et al. Identification of novel translational urinary biomarkers for acetaminophen-induced acute liver injury using proteomic profiling in mice. PLoS One 2012; 7: e49524.
Prot JM, Briffaut AS, Letourneur F, Chafey P, Merlier F, Grandvalet Y et al. Integrated proteomic and transcriptomic investigation of the acetaminophen toxicity in liver microfluidic biochip. PLoS One 2011; 6: e21268.
Merrick BA, Bruno ME, Madenspacher JH, Wetmore BA, Foley J, Pieper R et al. Alterations in the rat serum proteome during liver injury from acetaminophen exposure. J Pharmacol Exp Ther 2006; 318: 792–802.
Acknowledgements
This research was supported [in part] by the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH, and National Institute of Environmental Health Sciences grant P30ES10126, NIH grants R37 GM38149 and K23 RR21857-01, and The University of North Carolina General Clinical Research Center grant M000046. The raw and preprocessed data for the clinical study are publicly available in the Gene Expression Omnibus (GEO) database under accession number: GSE70784. The raw and preprocessed data for the overdose patient data are publicly available in the GEO database under accession number: GSE70786.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
PBW has served as a consultant for McNeil Corporation, a major manufacturer of acetaminophen-containing products.
Additional information
Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website
Rights and permissions
About this article
Cite this article
Bushel, P., Fannin, R., Gerrish, K. et al. Blood gene expression profiling of an early acetaminophen response. Pharmacogenomics J 17, 230–236 (2017). https://doi.org/10.1038/tpj.2016.8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/tpj.2016.8
This article is cited by
-
A Multi-Omic Mosaic Model of Acetaminophen Induced Alanine Aminotransferase Elevation
Journal of Medical Toxicology (2023)
-
Identification of Novel Regulatory Genes in APAP Induced Hepatocyte Toxicity by a Genome-Wide CRISPR-Cas9 Screen
Scientific Reports (2019)
-
Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis
The Pharmacogenomics Journal (2018)